the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0219] Dissolve intermediate 3 in an organic solvent (such as ethanol, etc.) at a low temperature (such as 0° C.), add an acidic solution (such as an ethanol solution containing HCl, etc.), and react for 5-30 hours. After the reaction is comple...
experiment example 1
[0234] Experimental Example 1: The effect of the compounds of the present invention on the relative expression of BSEP mRNA in HepG2 cells
[0235] (1) Test substance: the compound of the present invention, its chemical name and preparation method are shown in the preparation examples of each compound.
[0237] Control drug: PX-104, see background technology for specific structure.
[0238] (2) Experimental method:
[0239] ①Laying cells, adding compounds and collecting cells
[0240] Use trypsin to digest and collect the cells, and measure the cell concentration; according to the counting results, resuspend the cells to a density of 7.5e5cell / mL; inoculate 2 mL of cells in each well of a 6-well cell culture plate; place the culture plate in an incubator, at 37°C, 5%CO 2 Conditioned for 24 hours.
[0241] Dilute the compound to be tested to 0.3 and 3 mM with DMSO; take 5 μL of the stock solution diluted in the previous s...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
concentration
aaaaa
aaaaa
Login to View More
Abstract
The invention discloses an FXR receptoragonist. The invention belongs to the technical field of medicine, and specifically relates to a compound represented by formula (I), a pharmaceutically acceptable salt thereof, an ester thereof or a stereoisomer thereof, R 1 , R 2 , R 3 , M, L, L 1 , W, A, B, Q, m, n are as defined in the description; the present invention also relates to the preparation method of these compounds, the pharmaceutical preparation and the preparation method for the treatment and / or prevention of non-alcoholic The application of drugs in related diseases such as fatty liver, primary biliary cirrhosis, lipid metabolism disorder, diabetes complications and malignant tumors.
Description
technical field [0001] The present invention relates to FXR receptor agonists, their pharmaceutically acceptable salts, their esters and their stereoisomers, pharmaceutical preparations containing these compounds, and the compounds, their pharmaceutically acceptable salts, their esters and their stereoisomers Use of the isomer in the preparation of medicines for treating and / or preventing non-alcoholic fatty liver, primary biliary cirrhosis, lipid metabolism disorders, diabetic complications, malignant tumors and other related diseases mediated by FXR receptors . Background technique [0002] The FXR receptor (farnesoid X receptor) belongs to the nuclear receptor family of ligand-activated transcription factors and has a typical nuclear receptor structure, namely, a highly conserved DNA-binding domain (DBD) at the amino-terminus and a ligand-binding domain at the carboxyl-terminus. (LBD), amino-terminal ligand-independent transcriptional activation domain (AF1), carboxy-ter...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.